Edwards Lifesciences Overview

  • Founded
  • 1958

Founded
  • Status
  • Public

  • Employees
  • 15,700

Employees
  • Stock Symbol
  • EW

Stock Symbol
  • Investments
  • 37

  • Share Price
  • $78.14

  • (As of Friday Closing)

Edwards Lifesciences General Information

Description

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. Its key products include surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

Contact Information

Website
www.edwards.com
Formerly Known As
Edwards Laboratories, American Edwards Laboratories
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Therapeutic Devices
Stock Exchange
NYS
Primary Office
  • One Edwards Way
  • Irvine, CA 92614
  • United States
+1 (949) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Edwards Lifesciences Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$78.14 $78.21 $67.13 - $131.10 $48.4B 618M 5.11M $2.35

Edwards Lifesciences Financials Summary

In Thousands,
USD
TTM 30-Sep-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 50,392,896 79,771,934 56,253,740 47,971,099
Revenue 5,363,800 5,232,500 4,386,300 4,348,000
EBITDA 1,812,700 1,837,800 1,016,300 1,244,300
Net Income 1,458,800 1,503,100 823,400 1,046,900
Total Assets 8,638,200 8,502,600 7,237,100 6,488,100
Total Debt 686,800 690,300 694,900 678,800
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Edwards Lifesciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Edwards Lifesciences‘s full profile, request access.

Request a free trial

Edwards Lifesciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical d
Surgical Devices
Irvine, CA
15,700 As of 2021
000
000000000 000

000000

lum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proid
00000000 0000000
Princeton, NJ
0000 As of 0000
00000
000000 - 000 00000

000000

iqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut
00000000 0000000
Kalamazoo, MI
00000 As of 0000
00000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Edwards Lifesciences Competitors (43)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Integra Lifesciences Holdings Corporation Princeton, NJ 0000 00000 000000 - 000 00000
0000000 Formerly VC-backed Kalamazoo, MI 00000 00000000
00000000 Formerly VC-backed San Diego, CA 0000 00000 000000 - 000 00000
00000000 Formerly VC-backed London, United Kingdom 0000 000.00 000000000000
000000 0000000000 Corporation Marlborough, MA 00000 00000 000000&0
You’re viewing 5 of 43 competitors. Get the full list »

Edwards Lifesciences Patents

Edwards Lifesciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
DE-102022118354-A1 Heart valve repair devices and delivery devices therefor Pending 23-Jul-2021 000000000
DE-102022116343-A1 Heart valve repair devices and delivery devices therefor Pending 01-Jul-2021 000000000 00
US-20220249232-A1 Implanting grafts to valve leaflets for cardiac procedures Pending 10-Feb-2021 0000000000
US-20220241564-A1 Pulmonary vein shunting Pending 01-Feb-2021 0000000000
US-20220211500-A1 Tissue remodeling system and methods Pending 05-Jan-2021 A61F2/2454
To view Edwards Lifesciences’s complete patent history, request access »

Edwards Lifesciences Executive Team (39)

Name Title Board Seat Contact Info
Michael Mussallem Chief Executive Officer & Chairman
Scott Ullem Chief Financial Officer, Finance & Vice President
Bernard Zovighian General Manager & Vice President
Robert Sellers Chief Accounting Officer, Accounting & Controller, Finance
Sal Chiovari Chief Information Officer
You’re viewing 5 of 39 executive team members. Get the full list »

Edwards Lifesciences Board Members (15)

Name Representing Role Since
000000 00000000 Self Board Member 000 0000
000000 00000 Self Board Member 000 0000
000000 00000 Self Board Member 000 0000
0000000 000000000 Edwards Lifesciences Chief Executive Officer & Chairman 000 0000
00000000 000000000 Self Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

Edwards Lifesciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Edwards Lifesciences Investments & Acquisitions (37)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0-0000 22-Sep-2020 00000 0000 0000 Therapeutic Devices
0000000 00000 15-Jul-2020 00000 0000 0000 Decision/Risk Analysis
0000000 00000 28-Apr-2020 00000 0000 Decision/Risk Analysis
0000-00000 00 18-Apr-2019 0000000000 00000 Monitoring Equipment 000000000
Mitralign 12-Mar-2019 Merger/Acquisition Surgical Devices
You’re viewing 5 of 37 investments and acquisitions. Get the full list »

Edwards Lifesciences Subsidiaries (2)

Company Name Industry Location Founded
Valtech Cardio Therapeutic Devices Or Yehuda, Israel 2005
0000000 0000000000 Corporate Pension Irvine, CA 0000
To view Edwards Lifesciences’s complete subsidiaries history, request access »

Edwards Lifesciences ESG

Risk Overview

Risk Rating

Updated November, 29, 2022

19.33 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 15,613

Rank

00.00

Percentile

Healthcare

Industry

00 of 635

Rank

00.00

Percentile

Medical Devices

Subindustry

0. of 228

Rank

0.00

Percentile

To view Edwards Lifesciences’s complete esg history, request access »

Edwards Lifesciences Exits (13)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000000 01-Feb-2017 00000 00000 00 0000 Completed
  • 6 buyers
0000000000000 08-Dec-2014 00000 00000 00 0000 Completed
  • 9 buyers
000000 0000 000000 26-Jun-2013 00000 00000 00 000.00 Completed
  • 5 buyers
0000000000000 22-Feb-2013 00000 00000 00 0000 Completed
  • 9 buyers
Sphere Medical Holding 12-Apr-2010 Later Stage VC 00.00 Completed
  • 9 buyers
You’re viewing 5 of 13 exits. Get the full list »